Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 November 2006, Vol. 108, No. 9, pp. 2957-2964.
Prepublished online as a Blood First Edition Paper on July 6, 2006; DOI 10.1182/blood-2006-04-018218.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-018218v1
108/9/2957    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carreras, J.
Right arrow Articles by Banham, A. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carreras, J.
Right arrow Articles by Banham, A. H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 20, 2006
Accepted June 20, 2006

High numbers of tumor infiltrating FOXP3-positive regulatory T-cells are associated with improved overall survival in follicular lymphoma

Joaquim Carreras, Armando Lopez-Guillermo, Bridget C Fox, Lluis Colomo, Antonio Martinez, Giovanna Roncador, Emili Montserrat, Elias Campo*, and Alison H Banham

Hospital Clinic, Barcelona, Spain
Nuffield Department of Clinical Laboratory Sciences, University of Oxford,John Radcliffe Hospital,UK
Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain
Hospital Clinic, University of Barcelona, Barcelona, Spain

* Corresponding author; email: ecampo{at}clinic.ub.es.

The tumor microenvironment plays an important role in the biological behavior of follicular lymphoma (FL) but the specific cell subsets involved in this regulation are unknown. To determine the impact of FOXP3-positive regulatory T cells (Treg) in the progression and outcome of FL patients we examined samples from 97 patients at diagnosis and 37 at first relapse with an anti-FOXP3 monoclonal antibody. Tregs were quantified using computerized image analysis. The median overall survival (OS) of the series was 9.9 years and the FL International Prognostic Index (FLIPI) was prognostically significant. The median Treg percentage at diagnosis was 10.5%. Overall, 49 patients had more than 10% Tregs, 30 between 5-10% and 19 less than 5%, with a 5-year OS of 80%, 74% and 50%, respectively (p=0.001). Patients with very low numbers of Tregs (<5%) presented more frequently with refractory disease (p=0.007). The prognostic significance of Treg numbers was independent of the FLIPI. Seven transformed diffuse large-B-cell lymphomas (DLBCL) had lower Treg percentages (mean 3.3%) than FL grade 1,2 (mean 12.1%) or 3 (mean 9%) (p<0.02). In conclusion, high Treg numbers predict improved survival of FL patients, while a marked reduction in Tregs is observed on transformation to DLBCL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020